Department of Epidemiology and Community Health, Virginia Commonwealth University, Richmond, VA 23219, USA.
J Womens Health (Larchmt). 2012 Oct;21(10):1091-9. doi: 10.1089/jwh.2011.3434. Epub 2012 Sep 4.
Knee osteoarthritis (OA) increases healthcare use and cost. Women have higher pain and lower quality of life measures compared to men even after accounting for differences in age, body mass index (BMI), and radiographic OA severity. Our objective was to describe gender-specific correlates of complementary and alternative medicine (CAM) use among persons with radiographically confirmed knee OA.
Using data from the Osteoarthritis Initiative, 2,679 women and men with radiographic tibiofemoral OA in at least one knee were identified. Treatment approaches were classified as current CAM therapy (alternative medical systems, mind-body interventions, manipulation and body-based methods, energy therapies, and three types of biologically based therapies) or conventional medication use (over-the-counter or prescription). Gender-specific multivariable logistic regression models identified sociodemographic and clinical/functional correlates of CAM use.
CAM use, either alone (23.9% women, 21.9% men) or with conventional medications (27.3% women, 19.0% men), was common. Glucosamine use (27.2% women, 28.2% men) and chondroitin sulfate use (24.8% women; 25.7% men) did not differ by gender. Compared to men, women were more likely to report use of mind-body interventions (14.1% vs. 5.7%), topical agents (16.1% vs. 9.5%), and concurrent CAM strategies (18.0% vs. 9.9%). Higher quality of life measures and physical function indices in women were inversely associated with any therapy, and higher pain scores were positively associated with conventional medication use. History of hip replacement was a strong correlate of conventional medication use in women but not in men.
Women were more likely than men to use CAM alone or concomitantly with conventional medications.
膝关节骨关节炎(OA)增加了医疗保健的使用和成本。即使考虑到年龄、体重指数(BMI)和放射 OA 严重程度的差异,女性的疼痛和生活质量指标也高于男性。我们的目的是描述经放射学证实的膝骨关节炎患者中性别特异性补充和替代医学(CAM)使用的相关因素。
使用来自骨关节炎倡议的数据,确定了至少一侧膝关节有放射学胫股 OA 的 2679 名女性和男性。治疗方法分为当前 CAM 治疗(替代医疗系统、身心干预、手法和基于身体的方法、能量治疗和三种基于生物学的治疗)或常规药物使用(非处方或处方)。性别特异性多变量逻辑回归模型确定了 CAM 使用的社会人口统计学和临床/功能相关因素。
CAM 使用,无论是单独使用(女性 23.9%,男性 21.9%)还是与常规药物联合使用(女性 27.3%,男性 19.0%),都很常见。氨基葡萄糖(女性 27.2%,男性 28.2%)和软骨素(女性 24.8%;男性 25.7%)的使用不存在性别差异。与男性相比,女性更有可能报告使用身心干预(14.1%对 5.7%)、局部药物(16.1%对 9.5%)和同时使用 CAM 策略(18.0%对 9.9%)。女性较高的生活质量和身体功能指标与任何治疗方法呈负相关,而较高的疼痛评分与常规药物使用呈正相关。髋关节置换术的病史是女性常规药物使用的一个强烈相关因素,但不是男性。
女性比男性更有可能单独或同时使用 CAM 与常规药物。